Researchers at Yale University have used gene editing to successfully correct the most common mutation in the gene that causes cystic fibrosis (CF). A multidisciplinary team of Yale researchers developed a novel approach to edit the genetic defect. In order to correct the mutation, the team used synthetic molecules similar …